Leo Pharma’s inaccurate Innohep app has prompted a slap-down from the PMCPA. The U.K. | Leo Pharma’s inaccurate Innohep app ...

The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...

As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma ...

The FDA is raising efficacy questions over Lundbeck and Otsuka’s proposed combination of their Rexulti with Viatris’ Zoloft ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...

The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...

Now, after setting an innovative medicines sales record in the year’s second quarter, it appears J&J’s confidence was well placed.

Consumers are now almost as likely to say they learn about new medications from advertisements on linear or connected TV as ...

Fittingly enough, for its third acquisition in as many years, Deerfield Group has picked up Triple Threat Communications. | ...

Nostrum Labs, which declared bankruptcy last year and has since ceased operations, issued a voluntary recall for all lots of ...

Illustrating its confidence in its proprietary products, the Southern California company has announced an ambitious plan to ...